NCT02682511: Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension |
|
|
| Recruiting | 2 | 34 | US, RoW | Oral Ifetroban, Ifetroban, Oral Placebo | Cumberland Pharmaceuticals | Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited, Sclerosis, Progressive Systemic, Skin Diseases, Connective Tissue Diseases, Pathologic Processes, Autoimmune Diseases | 12/25 | 12/25 | | |
| Recruiting | N/A | 44 | US | Muscle Strengthening, General Physical Activity, Education | University of Arizona, Temple University, University of Melbourne | Osteoarthritis, Knee | 05/25 | 06/25 | | |